Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)
TWD 111.5
(1.36%)
TWD 111.5
(1.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 18.91 Million | 1.14 Million | 1.14 Million | 833 Thousand | 248 Thousand |
| Cost of Revenue | 7.71 Million | 77 Thousand | 65 Thousand | 47 Thousand | 14 Thousand |
| Gross Profit | 11.2 Million | 1.06 Million | 1.07 Million | 786 Thousand | 234 Thousand |
| Operating Expenses | 144.52 Million | 261.74 Million | 121.9 Million | 118.15 Million | 129.05 Million |
| Selling, General and Administrative Expenses | 91.87 Million | 67.42 Million | 38.85 Million | 41.89 Million | 46.53 Million |
| Research and Development Expenses | 52.64 Million | 194.32 Million | 83.05 Million | 76.26 Million | 82.52 Million |
| Other Expenses | - | -35.09 Million | 4.88 Million | 13.94 Million | - |
| Cost and Expenses | 152.24 Million | 261.82 Million | 121.96 Million | 118.19 Million | 129.07 Million |
| Operating Income | -133.32 Million | -288.94 Million | -113.54 Million | -98.81 Million | -128.82 Million |
| Interest Expense | 7.18 Million | 3.18 Million | 1.18 Million | 500 Thousand | 1.4 Million |
| Income Tax Expense | - | -37.94 Million | 15.2 Million | -6.24 Million | -5.49 Million |
| Earnings before Tax | -101.17 Million | -292.13 Million | -114.72 Million | -99.31 Million | -115.31 Million |
| Net Income | -92.03 Million | -254.18 Million | -121.58 Million | -93.07 Million | -109.82 Million |
| Earnings Per Share Basic | -0.81 | -2.29 | -1.10 | -0.88 | -1.07 |
| Earnings Per Share Diluted | -0.81 | -2.29 | -1.10 | -0.88 | -1.07 |
| Weighted Average Shares Outstanding | 113.26 Million | 111.13 Million | 110.86 Million | 105.71 Million | 103.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 113.26 Million | 111.13 Million | 110.86 Million | 105.71 Million | 103.06 Million |
| Gross Margin | 0.59 | 0.93 | 0.94 | 0.94 | 0.94 |
| EBIT Margin | -4.28 | -241.09 | -88.00 | -103.58 | -496.66 |
| Profit Margin | -4.87 | -222.39 | -106.37 | -111.73 | -442.84 |
| EBITDA | -81.04 Million | -275.56 Million | -100.58 Million | -86.28 Million | -101.86 Million |
| Earnings Before Tax Margin | -7.05 | -252.80 | -99.34 | -118.63 | -519.45 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.49 Million | 5.44 Million | 8.64 Million | 18.91 Million | 9.11 Million | 1.14 Million |
| Cost of Revenue | 2.1 Million | 2.26 Million | 2.08 Million | 7.71 Million | 2.25 Million | 1.25 Million |
| Gross Profit | 6.39 Million | 3.18 Million | 6.56 Million | 11.2 Million | 6.86 Million | -102 Thousand |
| Operating Expenses | 35.15 Million | 39.31 Million | 52.52 Million | 144.52 Million | 29.21 Million | 33.73 Million |
| Selling, General and Administrative Expenses | 21.99 Million | 28.65 Million | 30.78 Million | - | 20.96 Million | 22.4 Million |
| Research and Development Expenses | 13.16 Million | 10.65 Million | 21.74 Million | - | 8.24 Million | 11.33 Million |
| Other Expenses | -3.25 Million | -41 Thousand | -501 Thousand | -2.26 Million | -565 Thousand | -3.39 Million |
| Cost and Expenses | 37.26 Million | 41.57 Million | 54.6 Million | 152.24 Million | 31.46 Million | 34.99 Million |
| Operating Income | -22.36 Million | -24.63 Million | -34.81 Million | -93.98 Million | -16.15 Million | -21.78 Million |
| Interest Expense | 855 Thousand | 967 Thousand | 809 Thousand | 7.18 Million | 1.01 Million | 2.52 Million |
| Income Tax Expense | 103 Thousand | -1.46 Million | -2.6 Million | -9.13 Million | -296 Thousand | -3.9 Million |
| Earnings before Tax | -26.48 Million | -26.91 Million | -35.62 Million | -101.17 Million | -17.17 Million | -24.31 Million |
| Net Income | -25.55 Million | -25.45 Million | -33.02 Million | -92.03 Million | -16.87 Million | -20.4 Million |
| Earnings Per Share Basic | -0.22 | -0.22 | -0.29 | - | -0.15 | -0.18 |
| Earnings Per Share Diluted | -0.22 | -0.22 | -0.29 | - | -0.15 | -0.18 |
| Weighted Average Shares Outstanding | 116.14 Million | 115.71 Million | 112.88 Million | 113.26 Million | 112.5 Million | 113.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 116.14 Million | 115.71 Million | 112.88 Million | 113.26 Million | 112.5 Million | 113.43 Million |
| Gross Margin | 0.75 | 0.58 | 0.76 | 0.59 | 0.75 | -0.09 |
| EBIT Margin | -2.31 | -3.95 | -3.65 | - | -1.41 | -16.02 |
| Profit Margin | -3.01 | -4.68 | -3.82 | -4.87 | -1.85 | -17.76 |
| EBITDA | -19.59 Million | -21.51 Million | -31.58 Million | - | -12.82 Million | -18.41 Million |
| Earnings Before Tax Margin | -2.63 | -4.52 | -4.03 | -4.97 | -1.77 | -18.96 |
9685
YGFGF
SQFTP
MLGCF
0118
002408